Unichem Laboratories informs about press release

07 Jul 2020 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unichem Laboratories has informed that it has enclosed a press release on 7th July 2020, pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem’s Cyclobenzaprine Hydrochloride Tablets USP, 5 mg, 7.5 mg and 10 mg.

The above information is a part of company’s filings submitted to BSE.


Unichem Lab Share Price

323.00 10.40 (3.33%)
10-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1813.00
Dr. Reddys Lab 1313.90
Cipla 1333.10
Zydus Lifesciences 922.90
Lupin 2340.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×